PIK3CA and colorectal carcinoma: In summary, we observed a moderate rate of KRAS mutations (145/478; 30.3%) or PIK3CA mutations (67/384; 17.4%) and a very low rate of BRAF mutations (1/384; 0.3%) in a cohort of primary colorectal carcinomas.